Comorbidities and risk factors associated with newly diagnosed epilepsy in the U.S. pediatric population
Ahyuda Oh1, David J Thurman2, Hyunmi Kim3
1Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.
Insights
Children with newly diagnosed epilepsy often have neurobehavioral comorbidities. Neonatal seizures strongly predict epilepsy development, and epilepsy with risk factors increases intellectual disability risk.
Area of Science:
- Pediatric Neurology
- Neuroscience
- Public Health
Background:
- Neurobehavioral comorbidities are linked to epilepsy etiology, the condition itself, and antiepileptic drug side effects.
- Understanding these links is crucial for managing epilepsy in children.
Purpose of the Study:
- To examine the relationship between neurobehavioral comorbidities and potential risk factors in children with newly diagnosed epilepsy.
- To identify independent predictors for epilepsy development in pediatric populations.
Main Methods:
- Retrospective analysis of over 6 million children (≤18 years) using commercial claims data (2009-2013).
- Defined newly diagnosed epilepsy based on ICD-9-CM codes and antiepileptic drug prescriptions.
- Measured 12 neurobehavioral comorbidities and 11 putative epilepsy risk factors.
Main Results:
- Newly diagnosed epilepsy identified in 7,654 children (125 per 100,000).
- Neurobehavioral comorbidities were significantly more prevalent in children with epilepsy (60%) versus those without (23%).
- Neonatal seizures showed the strongest independent association with epilepsy development (OR=29.8).
- Children with both epilepsy and risk factors had a higher likelihood of intellectual disabilities (OR=13.4).
Conclusions:
- Neurobehavioral comorbidities are highly prevalent in children with newly diagnosed epilepsy.
- Neonatal seizures are a significant risk factor for developing epilepsy in children.
- Epilepsy in children with risk factors is strongly associated with intellectual disabilities, suggesting shared pathophysiology.
Abstract:
Neurobehavioral comorbidities can be related to underlying etiology of epilepsy, epilepsy itself, and adverse effects of antiepileptic drugs. We examined the relationship between neurobehavioral comorbidities and putative risk factors for epilepsy in children with newly diagnosed epilepsy. We conducted a retrospective analysis of children aged ≤18years in 50 states and the District of Columbia, using the Truven Health MarketScan® commercial claims and encounters database from January 1, 2009 to December 31, 2013. The eligible study cohort was continuously enrolled throughout 2013 as well as enrolled for any days during a baseline period of at least the prior 2years. Newly diagnosed cases of epilepsy were defined by International Classification of Diseases, Ninth Revision, Clinical Modification-coded diagnoses of epilepsy or recurrent seizures and evidence of prescribed antiepileptic drugs during 2013, when neither seizure codes nor seizure medication claims were recorded during baseline periods. Twelve neurobehavioral comorbidities and eleven putative risk factors for epilepsy were measured. More than 6 million children were analyzed (male, 51%; mean age, 8.8years). A total of 7654 children were identified as having newly diagnosed epilepsy (125 per 100,000, 99% CI=122-129). Neurobehavioral comorbidities were more prevalent in children with epilepsy than children without epilepsy (60%, 99% CI=58.1-61.0 vs. 23%, CI=23.1-23.2). Children with epilepsy were far more likely to have multiple comorbidities (36%, 99% CI=34.3-37.1) than those without epilepsy (8%, 99% CI=7.45-7.51, P<0.001). Preexisting putative risk factors for epilepsy were detected in 28% (99% CI=26.9-29.6) of children with epilepsy. After controlling for demographics, neurobehavioral comorbidities, family history of epilepsy, and other risk factors than primary interest, neonatal seizures had the strongest independent association with the development of epilepsy (OR=29.8, 99% CI=23.7-37.3, P<0.001). Compared with children with risk factors but no epilepsy, those with both epilepsy and risk factors were more likely to have intellectual disabilities (OR=13.4, 99% CI=11.9-15.0, P<0.001). The epilepsy and intellectual disabilities could share the common pathophysiology in the neuronal network.
More Related Videos
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
09:16Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury
Published on: June 21, 2019
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Glutamate Antagonists
